Bayer to Sell Off Animal Health Line

The once-dominating company is bowing out of the animal health industry.
VMD Editorial Staff
Published: December 04, 2018
Bayer Animal Health Bayer AG announced that it plans to sell its animal health product line in an effort to focus increased attention on other areas of its business.

Headquartered in Shawnee, Kansas for more than 50 years, Bayer Animal Health has 550 full-time-equivalent employees, making it the second largest animal health company in the Kansas City Animal Health Corridor. The company sells products in the livestock and pet industries.

According to a statement issued by Bayer CEO Werner Baumann, the moves were not initiated by litigation related to glyphosate, the active ingredient in the herbicide Roundup. The company’s animal health business “is well positioned in an attractive industry which will continue to grow,” Baumann said. But the company's primary focus areas—pharmaceuticals, consumer health, and crop science—are taking center stage. “Because of these priorities,” he continued, “we are convinced that Bayer is no longer the best owner for animal health.”

In addition to the animal health business, Bayer said it will sell consumer brands Coppertone and Dr. Scholl's as well as its 60% stake in German site services provider Currenta.

Sign up to receive the latest news from veterinary business experts.

Veterinarian's Money Digest
Partner Websites
MJH Associates
American Veterinarian
American Journal of Managed Care
Contemporary Clinic
Cure Hepatitis C
MD Magazine
Pharmacy Times
Specialty Pharmacy Times
Rare Disease Report
Targeted Oncology
About Us
Terms & Conditions
Privacy Policy
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Veterinarian's Money Digest® 2018
Intellisphere, LLC. All Rights Reserved.